Compounds > 2-acetamido-1,3,6-tri-o-acetyl-4-deoxy-4-fluoroglucopyranose
Page last updated: 2024-09-05

2-acetamido-1,3,6-tri-o-acetyl-4-deoxy-4-fluoroglucopyranose and B16 Melanoma

2-acetamido-1,3,6-tri-o-acetyl-4-deoxy-4-fluoroglucopyranose has been researched along with B16 Melanoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barthel, SR; Cedeno-Laurent, F; Dimitroff, CJ; Frank, MH; Hays, D; He, X; Matta, KL; Murphy, GF; Opperman, MJ; Schatton, T; Supko, JG; Zhan, Q1

Other Studies

1 other study(ies) available for 2-acetamido-1,3,6-tri-o-acetyl-4-deoxy-4-fluoroglucopyranose and B16 Melanoma

ArticleYear
Metabolic inhibition of galectin-1-binding carbohydrates accentuates antitumor immunity.
    The Journal of investigative dermatology, 2012, Volume: 132, Issue:2

    Topics: Acetylglucosamine; Amino Sugars; Animals; Galectin 1; Interferon-gamma; Interleukin-10; Leukosialin; Lymphoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; T-Lymphocytes, Cytotoxic

2012